Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy

NCT04436029

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Center for Cancer and Blood Disorders Bethesda, Maryland, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Stephenson Cancer Center Oklahoma University Health Science Centers Oklahoma City, Oklahoma, United States
  • Medical College of Wisconsin Madison, Wisconsin, United States
View Trial Details
Completed

A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China

NCT05896774

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
  • Sir Run Run Shaw Hospital Hangzhou, Zhejiang, China
View Trial Details
Completed

A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

NCT02181413

Conditions
Autologous Stem Cell Transplant, Blood Protein Disorders, Cardiovascular Diseases, +13 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Mayo Clinic - PPDS Rochester, Minnesota, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • Penn State Health Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
View all 227 locations
View Trial Details
Completed

Mobile Health Device Study for Myeloma Patients

NCT03006315

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

NCT02924402

Conditions
B-Cell Non-Hodgkins Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +50 more
Locations
  • Moores UC San Diego Cancer Center La Jolla, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Northside Hospital Atlanta, Georgia, United States
  • The University of Chicago Medicine Chicago, Illinois, United States
View all 23 locations
View Trial Details

Related conditions